Two COVID-19 Clinical Trials Seek to Enroll Pregnant Women
Two COVID-19 Clinical Trials Seek to Enroll Pregnant Women
Upon seeing pregnant women sick with COVID-19 at a University of Pennsylvania hospital, researchers there wrote trial protocols for blood transfusions to treat the disease that include expecting mothers.
Two COVID-19 Clinical Trials Seek to Enroll Pregnant Women
Two COVID-19 Clinical Trials Seek to Enroll Pregnant Women

Upon seeing pregnant women sick with COVID-19 at a University of Pennsylvania hospital, researchers there wrote trial protocols for blood transfusions to treat the disease that include expecting mothers.

Upon seeing pregnant women sick with COVID-19 at a University of Pennsylvania hospital, researchers there wrote trial protocols for blood transfusions to treat the disease that include expecting mothers.

clinical trial design
Support for Vaccine Challenge Trials Gains Momentum
Support for Vaccine Challenge Trials Gains Momentum
Shawna Williams | May 11, 2020
The idea of deliberately infecting volunteers with SARS-CoV-2 has garnered significant attention as a potential avenue to speedier development, as the World Health Organization weighs in with recommendations.
The Latest Drug Trials for Coronavirus
The Latest Drug Trials for Coronavirus
Ashley Yeager | Feb 18, 2020
Under careful watch of the World Health Organization, doctors will test a range of COVID-19 therapies, including HIV and flu antivirals, blood plasma infusions, and traditional Chinese medicines.
A New Way to Establish Cause and Effect in Epidemiology?
A New Way to Establish Cause and Effect in Epidemiology?
Rachael Moeller Gorman | Jan 1, 2020
A technique called Mendelian randomization is overturning the conclusions of observational studies in public health. But researchers question whether the method can overcome its fundamental limitations.
Interactive: Biomarkers in Blood Provide a Window into the Brain
Interactive: Biomarkers in Blood Provide a Window into the Brain
Shawna Williams | Dec 1, 2019
A look at some of the circulating molecules that may indicate various Alzheimer’s pathologies and serve as the bases of noninvasive tests for the disease.
The Hunt for a Blood Test for Alzheimer’s Disease
The Hunt for a Blood Test for Alzheimer’s Disease
Shawna Williams | Dec 1, 2019
Researchers hope circulating biomarkers will enable earlier detection and better monitoring of the neurodegenerative disorder—and perhaps help usher in new treatments.
Industry Partners Extensively Involved in Trials They Fund
Industry Partners Extensively Involved in Trials They Fund
Catherine Offord | Oct 5, 2018
A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy
John D. Loike and Jennifer Miller | Feb 1, 2017
What can be done to lower development costs and drug prices?
Opinion: Why Most TBI Studies Fail
Opinion: Why Most TBI Studies Fail
Donald Stein | Feb 24, 2016
Thoughts on how to redesign clinical trials for traumatic brain injury
NCI Gets Personal
NCI Gets Personal
Bob Grant | Jun 2, 2015
The National Cancer Institute is launching a Phase 2 trial matching patients with specific mutations to drugs tailored to those genetic changes.